Lisdexamfetamine Dimesylate Suppliers & Bulk Manufacturers
Available Forms: Tablets, Capsules
Available Strengths: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg
Reference Brands: Vyvanse (USA)
Category: Neurology
Lisdexamfetamine Dimesylate is a Neurology product available as Tablets, Capsules in strengths 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg. It corresponds to the reference brand Vyvanse (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Lisdexamfetamine dimesylate is a central nervous system stimulant used primarily for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It is also approved for the management of moderate-to-severe binge eating disorder in adults. As a prodrug of dextroamphetamine, lisdexamfetamine is converted to its active form in the body, allowing for a gradual onset of action and sustained therapeutic effects. This mechanism helps reduce the potential for abuse compared to immediate-release amphetamines and supports consistent symptom control over the day.
Lisdexamfetamine helps improve focus, attention, and impulse control in individuals with ADHD, while also reducing binge-eating episodes in adults with binge eating disorder. It is administered orally and is available in capsule, chewable tablet, and oral solution formulations, depending on patient needs. Off-label uses are similar to other pharmaceutical amphetamines, including the treatment of narcolepsy. Clinical studies have demonstrated its effectiveness in adults, with lisdexamfetamine recognized as one of the most effective treatments for adult ADHD. Its use requires medical supervision to monitor efficacy, dosing, and potential side effects.
Lisdexamfetamine Dimesylate — third party manufacturing & bulk supply
Lisdexamfetamine Dimesylate is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Lisdexamfetamine Dimesylate is supplied as Tablets, Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Lisdexamfetamine Dimesylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lisdexamfetamine Dimesylate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lisdexamfetamine dimesylate is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It is also indicated for the management of moderate to severe binge eating disorder in adults in select regions.
Lisdexamfetamine dimesylate is a chemically synthesized prodrug of dextroamphetamine formulated for oral administration in capsules, chewable tablets, or oral solution.
The trade names include Vyvanse in the USA and Elvanse in Europe and the UK.
It is developed and marketed by Shire Pharmaceuticals, now part of Takeda Pharmaceutical Company, globally.
The generic name is lisdexamfetamine dimesylate.
The brand names are Vyvanse and Elvanse.
Lisdexamfetamine dimesylate is manufactured in FDA-, EMA-, and MHRA-approved facilities, adhering to international pharmaceutical quality standards.
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View DetailsQuick Response Guaranteed | Verified Suppliers